Horizon Therapeutics

ACTIMMUNE

Manufacturer:

Horizon Therapeutics

Name:

ACTIMMUNE

Category:

J Code

HCPCS:

J9216

NDC(s):

75987-0111-10, 75987-0111-11,

Primary Type:

Cancer

Route of Administration:

Subcutaneous

About:

ACTIMMUNE is a Cancer drug manufactured by Horizon Therapeutics and administered via the Subcutaneous route of administration. The J Code: J9216 is aligned to the drug ACTIMMUNE.

Access Pricing and More By Registering